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The etiology of sporadic cardiac myxomas remains elusive. The tendency for these lesions to recur following resection, their
immunopathological characteristics, along with their histological and molecular proﬁle, may implicate the presence of an infective
agent in this type of tumor. In this study, we investigated the presence of herpes simplex virus (HSV) DNA in a cohort of cardiac
myxomas in a tertiary referral centre. Twenty-nine formalin-ﬁxed paraﬃn-embedded (FFPE) sporadic cardiac myxomas were
obtained, 17 of which were shown to be informative. These were compared to 19 macroscopically and microscopically normal
heart tissue specimens. The detection of HSV-1 and -2 genomic sequences was achieved with the use of a combined nested PCR-
Restriction Fragment Length Polymorphism methodology. The presence of HSV-1 and/or -2 DNA was demonstrated in 6 of 17
(35%)informativesporadiccardiacmyxomas,whereasnoHSVDNAwasdetectedinnormalhearttissues(P<0.01).Theexistence
ofHSV-1/2DNAinsporadiccardiacmyxomas,alongwithitsabsencefromnormalhearttissues,reinforcesthepossibilitythatHSV
infectionmightbeinvolvedinthedevelopmentoftheselesions.Ourﬁndingsraisethepointofanti-HSVmedicationpostsurgically
with a potential beneﬁt in reducing the rate of recurrences.
1.Introduction
Primary heart neoplasms are rare and encountered in
approximately 0.056–0.02% of autopsy series. These aﬀect
patients of all ages, with the vast majority being benign (75–
80%), and with the females more often aﬀected than males.
Myxoma is the commonest primary cardiac neoplasm with
a malignant potential, accounting for approximately 75% of
all cases [1], having an annual incidence of about 1/106 and a
recurrence rate of 2-3% [2, 3]. Some cases are familial and
appear to have an autosomal dominant transmission [4].
These are frequently single, aﬀecting mainly the atrial fossa
ovalis in the left atrium [1] as part of the Carney complex,
which has been found to be associated with the germline
mutation PRKAR1A encoding Protein Kinase A Regulatory
subunit type 1A. Only familiar forms of myxomas have been
associated with the mutation; sporadic cases of myxomas
have no association with it [4, 5]. Sporadic myxomas,
represent the majority of the diagnosed myxomas and their
etiology remains elusive. Although recurrences of myxomas
have mostly been attributed to incomplete excision, this
explanation does not account for recurrences at distant sites
within the atria [6].
Various indications point towards the involvement of
Herpes Simplex Viruses (HSVs) in sporadic cardiac myxoma
pathogenesis. The endocardium of the atrial septum, where
the atrial myxoma mainly originates from, is rich in sensory
nerves. In turn, myxoma cells appear to be derived from
endocardial sensory nerve tissue [7]. The life cycle of HSV
is characterized by latency in sensory or autonomic ganglia2 Journal of Biomedicine and Biotechnology
that can be maintained for life in the host. Periodically,
the virus can be reactivated by stimuli causing either viral
shedding or recurrent infection of the aﬀected nerve [8]. In
addition, a report in Chinese patients has suggested HSV-
1 presence in sporadic atrial myxomas [9]. Our aim was
to examine whether HSV-1, 2 DNA could be detected in a
cohort of patients with cardiac myxomas more frequently
than in normal control hearts.
2.MaterialsandMethods
Twenty-nine tissue specimens originating from patients
with typical clinicopathological features of sporadic cardiac
myxomawereexamined.Thetissuespecimenswereobtained
from Onassis Cardiac Surgery Centre (1996–2003) from
patients admitted for surgical removal of the lesion. Tissue
specimens from 19 macroscopically and microscopically
normal hearts, provided by the forensic department of the
university,servedascontrols.Speciﬁccarewastakensoasthe
material from the normal controls was taken from the atria.
Thecontrolspecimenswerematchedforageandsexwiththe
myxomaspecimens.Alltissueswereformalin-ﬁxed,paraﬃn-
embedded. Use of the myxoma material followed written
permission by the subjects, while the local Ethics Committee
approvedfurtherexperimentation.Thestudywasperformed
according to the requirements of the revised (1983) Helsinki
Declaration of 1975. Whole blood from previously tested
HSV-1/2-infected patients was used as positive control.
Histopathological evaluation was performed by hematoxylin
and eosin staining.
DNA extraction was performed according to the conven-
tional phenol/chloroform protocol with slight modiﬁcations
[10]. The IFN-γ house-keeping gene was used to assess the
integrity and yield of the extracted DNA [11].
The primers used in the ﬁrst-round ampliﬁcation
reaction are the following: 5 -TGCTCCTACAACAAGTC-3 
and 5 -CGGTGCTCCAGGATAAA-3  with annealing tem-
perature 55◦C and respective product size 200bp. In the
second-round ampliﬁcation reaction the following primers
were employed: 5 -ATCCGAACGCAGCCCCGCTG-3 
and 5 -TCTCCGTCCAGTCGTTTATCTTC-3  (reverse)
with annealing temperature 60◦C and corresponding
product size 142bp. They are based on those reported
for the conserved HSV glycoprotein D gene ((GenBank
accession numbers: X14112 (HSV-1), Z86099 (HSV-2))
[12]. PCR reactions were performed as previously
described [11]. The primers for Interferon γ (IFNγ) are the
following: 5 -CTCTTTTCTTTCCCGATAGGT-3  and 5 -
CTGGGATGCTCTTCGACCTCG-3  with annealing tem-
perature 57◦C and respective product size 151bp.
Restriction Fragment Length Polymorphism (RFLP)
analysis was performed on HSV-positive nested-PCR prod-
ucts, digested with the restriction enzyme MspI( N e w
England Biolabs) at 37◦C for 4h. RFLP digests were size-
fractionated by electrophoresis on 7.5%-polyacrylamide gel,
stainedwithethidiumbromideandphotographedunderUV
light.
Data are expressed asmean ± 1 standard deviation (S.D.)
for continuous variables and as frequency (percentage %)
Table 1: Characteristics of the myxoma patients (all and informa-
tive cases) and the normal controls; no statistical signiﬁcance was
observed in baseline characteristics between groups.
Characteristics
Myxoma
patients
N = 29
Normal
controls
N = 19
Informative
myxomas
N = 17
Age (mean ±SD) years 58 ±13 61 ±18 57 ±14
Female n (%) 25 (86.2) 16 (84.2) 14 (82.4)
for categorical data. The normality of the distributions was
assessed with Kolmogorov-Smirnov test and graphical meth-
ods. Comparisons of continuous variables were performed
using Mann-Whitney’s U nonparametric test. Categorical
data were compared by Fisher’s exact test. The necessary
numberofcontrolsampleswasdeterminedbypoweranalysis
(G∗Power 3, Universit¨ at Kiel, Germany). Diﬀerences were
considered to be statistically signiﬁcant if the null hypothesis
could be rejected with >95% conﬁdence (P<0.05).
3. Results
The demographic characteristics of the myxoma patients (all
and informative cases) and the normal control hearts are
depicted in Table 1. Twenty patients presented with various
clinical manifestation (strokes, pulmonary embolization),
while for the remaining 9 patients the myxoma was an
incidental ﬁnding on cardiac ultrasound. The myxoma was
excised from the right atrium in 22 patients (75.9%) from
the left atrium in 2 patients (6.9%), while in 5 (17.2%)
patients the lesion was excised from the right ventricle.
Histological evaluation clearly exhibited the characteristic
gel-like stroma of mucopolysaccharides on hematoxylin-
eosin (H&E) staining (Figure 1(a))[ 13]. In this cohort of
specimens, 17/29 cases produced appropriate DNA yields for
further HSV detection. A clear 142-bp band corresponding
to both HSV-1 and HSV-2 genomes was obtained following
PCR ampliﬁcation in 6 myxoma cases, accounting for 35.3%
of the sample (Figure 1(b)). In contrast, HSV DNA was
absent from the 19 normal heart tissues tested (P<0.01)
(Figure 2). Five of the infected cases originated from female
patients from the left atrial cavity, and one specimen was
removed from the right atrial chamber of a male patient.
RLFP analysis allowed the identiﬁcation of the infectious
viral type in 4/6 HSV-positive cases (Figure 2). In fact,
two atrial myxomas were found to harbor HSV-1, one was
infected by HSV-2, while both viruses were present in an
additional case (Figure 3).
4. Discussion
This study has shown that HSV DNA is detected signiﬁcantly
more frequently in cardiac myxomas than in their normal
counterparts. The demonstration of HSV-1 infection lies
in accordance with a study performed on the Chinese
population, which reported on the occurrence of the virus in
asubsetofsporadiccardiacmyxomas[9].Theauthorsfound
that the examination of the viral DNA is more sensitive thanJournal of Biomedicine and Biotechnology 3
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Figure 1: (a) Histological evaluation of representative HSV-positive and HSV-negative cardiac myxoma cases. Hematoxylin-eosin (H&E)
staining of myxoma tissue sections revealed sparsely cellular lesions with a characteristic gel-like stroma of acid mucopolysaccharides,
containing individual small cells with sparse cytoplasms forming stellate protrusions into the stroma. (i) HSV-negative left atrial myxoma
sample (case 1). (ii) HSV-positive right ventricle myxoma sample (case 7) (×200 magniﬁcation, H&E staining). (b) Detection of HSV DNA
in representative atrial myxoma specimens. M: 100bp molecular marker (New England Biolabs), 1–13: atrial myxoma samples, cases 1, 2,
4–6, 8–13: HSV-negative samples, cases 3, 7: HSV-positive samples, 14: positive control (blood sample), and 15: negative control (normal
heart tissue).
INFγ (151 bp)
M 12345678
Glycoprotein D (142 bp)
Figure 2: Absence of HSV DNA from normal heart tissues. HSV
and IFN-γ PCR in representative cases with normal heart tissues.
PCR. M: 100bp molecular marker (New England Biolabs), 1 and
7: positive control (blood sample), 2–6: normal heart tissues, and
8: negative control (distilled water). IFN-γ was used to assess the
quality and quantity of the examined DNA.
the immunohistochemical evaluation of HSV-1 in cardiac
myxomas,whichmayprovideanexplanationfortheﬁndings
of a recent study showing no association between HSV and
cardiac myxomas [14]. The present study was adequately
powered to detect statistical diﬀerences between cardiac
myxomas and normal hearts regarding the presence of HSV.
In addition, the detection of HSV-2 as the infectious agent
in two myxoma cases reﬂects a novel ﬁnding. Two others
members of Herpesviridae family have been long ago estab-
lished as oncogenic agents, Epstein-Barr virus (EBV) and
HumanHerpesVirustype8(HHV-8)[15].EBVisassociated
with the development of Burkitt’s lymphoma, Hodgkin’s
lymphoma (B-cell), and nasopharyngeal carcinoma, and
HHV-8 is having a causal role for the development of
sarcoma Kaposi.
Commonclinicalmanifestationsofmyxomasarestrokes,
peripheral or pulmonary embolization, fever, weight loss,
high sedimentation rate, anemia, and leucocytosis [1]. At
150 bp
100 bp
HSV-2 fragment (142 bp)
HSV-1 fragment (98 bp)
M 12345
Figure 3: HSV typing via RFLP analysis. Electrophoresis of rep-
resentative nested-PCR products, positive for HSV, digested with
MspI. M: 50bp marker (New England Biolabs), 1: undigested
nested-PCR product (142bp), 2: positive control containing both
HSV-1 (98bp) and HSV-2 (142bp) genomic sequences, 3-4: cases
infected by HSV-1, and 5: case harboring both HSV-1 and -2.
an immunological level, a CD8+ cellular inﬁltrate and
elevated IL-6 levels have been observed [9, 16, 17]. Addi-
tionally, the molecular proﬁle commonly associated with
neoplastic disease, such as mutations in gatekeeper genes,
is absent [18]. It is likely that, in certain susceptible
individuals, the development of cardiac myxoma is the
result of an intense inﬂammatory process, secondary to an
inciting agent. In turn persistent inﬂammation increases
DNA mutations and overall genomic instability favoring4 Journal of Biomedicine and Biotechnology
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Figure 4: Neural crest embryological remnants in the adult heart and localization of cardiac myxomas. (a) Embryonic heart. Blue stars
indicate the localization of neural crest cells from the pharyngeal mesoderm, which migrate through the aortic arch arteries to the outﬂow
tract and the endocardial cushions. (b) Newborn heart. The Fossa ovalis in the adult heart is an embryonic remnant of the foramen ovale,
which closes shortly after birth. (c) Adult heart. Red crosses indicate the attachment of HSV particles to cardiac myxomas. Blue stars indicate
autonomic nerve ﬁbers. RA: right atrium, RV: right ventricle, LA: left atrium, and LV: left ventricle.
neoplastic transformation [19]. It has been well established
that chronic inﬂammation through several inﬂammatory
mediators including cytokines, reactive oxygen, and nitrogen
species induce genetic instability, a hallmark of cancer [20].
Alternatively, and not mutually exclusively, the infectious
agent may disrupt critical signaling pathways implicated in
cell control. Concerning Herpesviridae family, both EBV
and HHV-8 target crucial components of cellular machinery
including NFκB and p53 as well as the Wnt pathway
through the stabilization of b-catenin [15]. The latter is
achieved by the production of certain viral proteins which
abrogate the ubiquitination of b-catenin. Interestingly, HSV-
1 encodes UL-36, a protein with deubiquitinating activity
[21]. The examination of the eﬀect of UL-36 in b-catenin
stabilization remains an attractive issue that may shed light
on the potential oncogenic properties of HSV-1. Altogether,
the above may provide an explanation for the presence of
chromosomal aberrations including aneuploidy in a subset
of cardiac myxomas [22, 23].
Mucopolysaccharides found in cardiac myxomas have
been implicated as receptors of HSV particles during infec-
tion [24]. The fact that 6 cardiac myxoma specimens were
found to be HSV positive in contrast to the complete absence
of HSV in the control group despite the reported prevalence
of these viruses in the general population [25] renders the
possibility of endocardial infection to be a random event
rather unlikely.
The role of HSVs in the pathogenesis of cardiac myxoma
is still unclear. Whether the viruses are among the inciting
agents for the development of the lesion or simply represent
opportunistic pathogens with a tropism for myxomatous
endocardium remains to be answered [9]. One may assume
that cardiac myxomas arise as a direct consequence of lytic-
HSV infection. The viral life cycle is characterized by latency
in sensory or autonomic ganglia. Periodically, the virus can
be activated causing viral shedding or recurrent infection
[8]. The majority of myxomas occur on the left atrial cavity,
and the most common site of attachment is the left atrial
border of the fossa ovalis [1]. It is well established that
the endocardium of the atrial septum is rich in autonomic
nerve ﬁbers and, thus, may serve as a portal for the entry
of HSVs. Experimentally induced HSV carditis in mice
suggests that HSV-1 is able to aﬀect the endocardium via
these nerve cells [26]. Furthermore, studies on sporadic
atrial myxomas have shown that these lesions express anti-
gens, which are representative of a neural cell component,
such as neurone-speciﬁc enolase, S100, synaptophysin-38,
CD34, alpha-smooth muscle actin, and calretinin [7, 13].
Of note, IL-6, detectable at high levels in myxomas, has
been associated with reactivation of latent HSV [16, 17].
Moreover, during embryonic development, noncardiac cells,
particularly neural crest cells from the pharyngeal meso-
derm, migrate through the outﬂow tract to the endocardial
cushions [27, 28] (Figures 4(a) and 4(b)). The existence of
cardiac neural crest cells is of nodal importance, since their
absence results in congenital malformations [27]. However,
theirfatefollowingheartdevelopmentispoorlydeﬁned[29].
It is possible that HSV infects these embryological remnants,
hence causing an intense inﬂammatory reaction, leading
to myxoma development. These observations regarding the
embryological origins of endocardial tissue may account
both for HSV tropism towards this site and for the frequent
recurrence of cardiac myxomas (Figure 4(c)).
Of particular interest is the recognition of HSV-2 as
a potential cardiovascular pathogen. The virus has been
implicated in coronary artery disease and carotid atheroscle-
rosis [30]. Moreover, infection by HSV-2 seems to convey
an increased risk for cardiovascular death and myocardial
infarction [31].
This study has a number of limitations. Its major
limitation is the small sample size. However, cardiac myx-
omas are extremely rare and the investigators powered the
study enough to detect signiﬁcant diﬀerences, if present.
In addition, the cardiac samples that served as controls
were received from apparently healthy hearts. Even if the
investigators made sure that no cardiac involvement hadJournal of Biomedicine and Biotechnology 5
led to the death of the subjects and the hearts were found
to be microscopically healthy, the possibility of a possible
underlying cardiac disease cannot be excluded.
Since myxomas are clinically signiﬁcant lesions, with
potential life-threatening sequelae that aﬀect patients of all
ages and the only available treatment is complete resection of
the tumor, the identiﬁcation of possible underlying treatable
causes is extremely important. Our work supports the
occurrence of HSV in a subset of sporadic cardiac myxomas.
While further studies are needed to clarify the role of HSV1
in cardiac myxoma pathogenesis, it is conceivable to trial
suppressive anti-HSV drugs, such as acyclovir, after surgery
in the HSV-positive patients, in order to avoid a possible
recurrence of sporadic cardiac myxomas.
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